A detailed history of Cim Investment Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Cim Investment Management Inc holds 5,450 shares of ABT stock, worth $628,385. This represents 0.18% of its overall portfolio holdings.

Number of Shares
5,450
Previous 5,508 1.05%
Holding current value
$628,385
Previous $626,000 9.58%
% of portfolio
0.18%
Previous 0.19%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$100.73 - $112.44 $5,842 - $6,521
-58 Reduced 1.05%
5,450 $566,000
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $11,177 - $13,410
-117 Reduced 2.08%
5,508 $533,000
Q2 2023

Aug 09, 2023

BUY
$100.78 - $112.29 $1,209 - $1,347
12 Added 0.21%
5,625 $613,000
Q1 2023

May 16, 2023

BUY
$96.86 - $114.01 $23,440 - $27,590
242 Added 4.51%
5,613 $568,000
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $12,452 - $14,609
-131 Reduced 2.38%
5,371 $589,000
Q2 2022

Sep 02, 2022

SELL
$102.07 - $123.37 $2,755 - $3,330
-27 Reduced 0.49%
5,502 $598,000
Q1 2022

May 17, 2022

SELL
$114.02 - $139.04 $684 - $834
-6 Reduced 0.11%
5,529 $654,000
Q4 2021

May 19, 2022

SELL
$115.53 - $141.46 $650,318 - $796,278
-5,629 Reduced 50.42%
5,535 $779,000
Q4 2021

Feb 02, 2022

BUY
$115.53 - $141.46 $639,458 - $782,981
5,535 Added 98.33%
11,164 $1.44 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $3,499 - $3,871
-30 Reduced 0.53%
5,629 $665,000
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $18,195 - $21,419
-172 Reduced 2.95%
5,659 $656,000
Q1 2021

May 20, 2021

SELL
$108.84 - $128.23 $21,332 - $25,133
-196 Reduced 3.25%
5,831 $699,000
Q4 2020

Feb 17, 2021

SELL
$105.0 - $114.42 $9,030 - $9,840
-86 Reduced 1.41%
6,027 $660,000
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $5,315 - $6,454
-58 Reduced 0.94%
6,113 $665,000
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $472,513 - $604,758
6,171 New
6,171 $564,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cim Investment Management Inc Portfolio

Follow Cim Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.